Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
BeiGene
Jubilant DraxImage Inc.
DNAtrix, Inc.
Boehringer Ingelheim
Merck Sharp & Dohme LLC